文献速递妇科

超声影像组学模型预测高危子宫内膜癌的研发与验证

Developing and validating ultrasound-based radiomics models for predicting high-risk endometrial cancer.
PubMed 文献 · Ultrasound Obstet Gynecol · 2022-01-01

多中心回顾性观察研究,用2016–2019年两家中心术前超声图像构建影像组学、临床-超声及混合模型,训练集396例、外部验证集102例。验证集中预测高危子宫内膜癌以临床-超声模型AUC最高(0.90),混合模型特异度最高(91.0%);加入影像组学特征未显著提升性能。

要点

  • 外部验证集中临床-超声模型预测高危子宫内膜癌AUC 0.90,优于纯影像组学模型0.80。
  • 混合模型预测高危癌特异度91.0%,但敏感度仅67.3%。
  • 影像组学特征加入临床-超声模型未见性能明显提升。

核心结论

  • 影像组学对区分低危与高危子宫内膜癌有一定能力,对高危癌区分能力更好,但加入临床-超声模型后性能无明显提升,仍需更多有效性研究验证。

研究设计与样本

  • 多中心、回顾性、观察性研究;训练集来自罗马中心396例,外部验证集来自米兰中心102例,均为2016–2019年经组织学确诊并接受有经验检查者术前超声的连续子宫内膜癌患者。
  • 对超声图像行影像组学分析,训练集单因素分析中显著的特征进入多因素分析并构建随机森林影像组学模型、临床-超声二元逻辑回归模型及混合模型,并在验证集测试。

主要发现

  • 验证集预测高危子宫内膜癌:影像组学模型AUC 0.80、敏感度58.7%、特异度85.7%(最佳界值0.41);临床-超声模型AUC 0.90、敏感度80.4%、特异度83.9%(界值0.32);混合模型AUC 0.88、敏感度67.3%、特异度91.0%(界值0.42)。
  • 验证集预测低危子宫内膜癌:影像组学模型AUC 0.71、敏感度65.0%、特异度64.5%(界值0.38);临床-超声模型AUC 0.85、敏感度70.0%、特异度80.6%(界值0.46);混合模型AUC 0.85、敏感度87.5%、特异度72.5%(界值0.36)。

关键数值与推荐

  • 高危子宫内膜癌定义采用2016年ESMO-ESGO-ESTRO联合标准。
  • 验证集高危癌预测中临床-超声模型AUC 0.90为三种模型最高;混合模型特异度91.0%为最高。

临床怎么用

  • 术前超声联合临床特征可用于辅助区分高危与低危子宫内膜癌,影像组学可作补充但增益有限。
  • 模型输出仍属研究阶段,不宜单独用于临床风险分层决策。

局限性

  • 为回顾性观察研究,仅两家中心数据,外部验证样本102例。
  • 作者指出仍需其他疗效研究与进一步有效性研究验证模型性能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The primary aim of this study was to develop and validate radiomics models, applied to ultrasound images, capable of differentiating from other cancers high-risk endometrial cancer, as defined jointly by the European Society for Medical Oncology, European Society of Gynaecological Oncology and European Society for Radiotherapy & Oncology (ESMO-ESGO-ESTRO) in 2016. The secondary aim was to develop and validate radiomics models for differentiating low-risk endometrial cancer from other endometrial cancers. METHODS: This was a multicenter, retrospective, observational study. From two participating centers, we identified consecutive patients with histologically confirmed diagnosis of endometrial cancer who had undergone preoperative ultrasound examination by an experienced examiner between 2016 and 2019. Patients recruited in Center 1 (Rome) were included as the training set and patients enrolled in Center 2 (Milan) formed the external validation set. Radiomics analysis (extraction of a high number of quantitative features from medical images) was applied to the ultrasound images. Clinical (including preoperative biopsy), ultrasound and radiomics features that were statistically significantly different in the high-risk group vs the other groups and in the low-risk group vs the other groups on univariate analysis in the training set were considered for multivariate analysis and for developing ultrasound-based machine-learning risk-prediction models. For discriminating between the high-risk group and the other groups, a random forest model from the radiomics features (radiomics model), a binary logistic regression model from clinical and ultrasound features (clinical-ultrasound model) and another binary logistic regression model from clinical, ultrasound and previously selected radiomics features (mixed model) were created. Similar models were created for discriminating between the low-risk group and the other groups. The models developed in the training set were tested in the validation set. The performance of the models in discriminating between the high-risk group and the other groups, and between the low-risk group and the other risk groups for both validation and training sets was compared. RESULTS: The training set comprised 396 patients and the validation set 102 patients. In the validation set, for predicting high-risk endometrial cancer, the radiomics model had an area under the receiver-operating-characteristics curve (AUC) of 0.80, sensitivity of 58.7% and specificity of 85.7% (using the optimal risk cut-off of 0.41); the clinical-ultrasound model had an AUC of 0.90, sensitivity of 80.4% and specificity of 83.9% (using the optimal cut-off of 0.32); and the mixed model had an AUC of 0.88, sensitivity of 67.3% and specificity of 91.0% (using the optimal cut-off of 0.42). For the prediction of low-risk endometrial cancer, the radiomics model had an AUC of 0.71, sensitivity of 65.0% and specificity of 64.5% (using the optimal cut-off of 0.38); the clinical-ultrasound model had an AUC of 0.85, sensitivity of 70.0% and specificity of 80.6% (using the optimal cut-off of 0.46); and the mixed model had an AUC of 0.85, sensitivity of 87.5% and specificity of 72.5% (using the optimal cut-off of 0.36). CONCLUSIONS: Radiomics seems to have some ability to discriminate between low-risk endometrial cancer and other endometrial cancers and better ability to discriminate between high-risk endometrial cancer and other endometrial cancers. However, the addition of radiomics features to the clinical-ultrasound models did not result in any notable increase in performance. Other efficacy studies and further effectiveness studies are needed to validate the performance of the models. © 2021 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Moro F, Albanese M, Boldrini L, et al. Developing and validating ultrasound-based radiomics models for predicting high-risk endometrial cancer. Ultrasound Obstet Gynecol. 2022. PMID: 34714568. doi:10.1002/uog.24805

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。